
## **Trustees’ Annual Report for the period** 

**From 01/04/2024         Period start date   To 31/03/2025                Period end date** 

**Charity name:** TEAM LUKE FOUNDATION 

## **Charity registration number:1185232** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|To preserve & protect good health for the<br>public benefit of children with Neuroblastoma<br>by:<br>a Raising awareness & sharing information<br>about Neuroblastoma amongst the general<br>public.<br>b Encouraging & supporting equality of<br>access to support & information for parents<br>& families of children with Neuroblastoma as<br>the Trustees see fit.<br>c Relieving the needs of parents & families<br>of children with Neuroblastoma through<br>practical support & services as the Trustees<br>see fit.<br>d Providing funding/grants for research jnto<br>Neuroblastoma causes, treatment & better<br>diagnosis.|
|**Summary of the main**<br>**activities in relation to**<br>**those purposes for the**<br>**public benefit, in**<br>**particular, the activities,**<br>**projects or services**<br>**identified in the accounts.**|**Para 1.17 and**<br>**1.19**|a Regularly sharing information to the<br>general public through all social media<br>platforms, presentations to professional<br>bodies, local businesses, social groups,<br>community-based centres, including facts &<br>figures about symptoms, diagnosis,<br>prognosis & treatment of Neuroblastoma.<br>b Continuing to support NHS research<br>initiatives to improve parental involvement in<br>the design & delivery of supportive<br>interventions, including REDMAPP, which is<br>a research project to facilitate parental<br>involvement in decision-making in relation to<br>treatment options. Contributing to<br>professional articles in the public domain to|





|||facilitate & support better access to<br>information & support for parents.<br>c Providing direct support/signposting<br>through social media messaging for advice &<br>information. Developing knowledge of<br>current treatment landscape to ensure<br>accuracy of advice.<br>d Engaging professionally with the Institute<br>of Cancer Research & establishing a<br>research partnership to fund a Senior<br>Research Scientist. Engaging with other<br>leading bodies to establish partnerships for<br>collaborative working, e.g. CCLG, SKC.|
|---|---|---|
|**Statement confirming**<br>**whether the trustees have**<br>**had regard to the guidance**<br>**issued by the Charity**<br>**Commission on public**<br>**benefit**|**Para 1.18**|TLF can confirm that all trustees have had<br>full regard to the Charity Commission’s<br>guidance on public benefit & have taken it<br>into account in respect of all decisions to<br>which it is relevant.|



## **Additional information (optional) You may choose to include further statements where relevant about:** 

||<br>**SORP reference**||
|---|---|---|
|**Policy on grant making**|**Para 1.38**|TLF’s criteria for consideration of the<br>provision of grants is subject to the following<br>criteria (see below) & reflects an agreed<br>amendment to the original upper limit for a<br>single grant from £10000 to £15000. This<br>was discussed & agreed by all Trustees in<br>FY 2020/21.|
|Policy on social investment<br>including program related<br>investment|Para 1.38|a. Available only to officially-recognised<br>organisations & charities who are working in<br>furtherance of the same or very similar<br>purpose, principles & objectives as TLF.<br>b Unless formally agreed by all Trustees, the<br>maximum amount of a single grant will be<br>£15000.<br>c Grants will be conditional on their use<br>being consistent with the purpose, principles<br>& objectives of TLF & be subject to a<br>rigorous process prior to approval.|
|Contribution made by<br>volunteers|Para 1.38|TLF is generously supported by a proactive<br>network of willing volunteers, social groups,<br>community associations & businesses who<br>all contribute to fundraising events by<br>providing practical help, participating in<br>events, e.g. playing rugby, hiking, cycling,<br>running, swimming etc., and/or donating<br>money or providing sponsorship. Their<br>contribution is priceless & TLF continues to<br>be hugely grateful for their unstinting loyalty|





& support. It has a massive impact on our ability to raise significant funds & successfully achieve our objectives. Other 

## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|Our main achievements for this period were:<br>a Continuing our support for the Institute of<br>Cancer Research. We continue to be hugely<br>impressed by their work, passion & the<br>actual & potential impact of their<br>achievements in respect of the diagnosis &<br>treatment of children’s cancer.<br>b. Continuing to reach out to & engage with<br>other charities with similar values &<br>objectives to encourage collaboration & be<br>better together.<br>c. Taking on & supporting new physical<br>challenges to generate increased funding &<br>support.<br>d. Engaging with social, community &<br>business groups to raise awareness.<br>e. Continuing our participation in the<br>REDMAPP study to support parents of<br>children with Neuroblastoma who have<br>relapsed.<br>f.  Raising our profile more widely.<br>g. Continuing our campaign to raise<br>awareness of the signs & symptoms of<br>children’s cancer.<br>h. Supporting newly-diagnosed children on<br>admission to hospital.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Achievements against<br>objectives set|Para 1.41|
|---|---|





|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|---|---|---|
|Investment performance<br>against objectives|Para 1.41||
|Other|||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|We are on track with our expected spend.<br>Payments continue to reflect our planning<br>around new activities, campaigns & projects<br>over the next few years. Overall, our<br>financial position remains very stable.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|As our financial position remains stable, we<br>are able to make full use of our funds & have<br>no cause to hold a fixed level of reserves. As<br>it stands, we have sufficient levels to<br>manage any unexpected drop in funding &<br>we have always held the view that TLF will<br>seek to use the funds it raises to fulfil its<br>objectives rather than focusing on growing<br>its financial resources exponentially. But we<br>continue to be very mindful of managing<br>financial risk in difficult economic times.|
|Amount of reserves held|Para 1.22|No fixed level has been set but we monitor<br>our finances closely & our minimum<br>resources remain steady at a level<br>appropriate to the aims & objectives of our<br>charity.|
|Reasons for holding zero<br>reserves|Para 1.22|Although funding medical research is one of<br>our key objectives, we are also passionate<br>about raising awareness & working with<br>other charities to develop & improve access<br>to information about Neuroblastoma, &<br>childhood cancer more generally. It is also<br>something which can be achieved with<br>comparatively lower levels of financial<br>resourcing. Although we have never found<br>ourselves in this situation, it means we have<br>the capacity to manage our income more<br>effectively across different projects if funding<br>levels fluctuated or dipped significantly. But<br>we will continue to review our position & be<br>receptive to the possibility of fixing an<br>appropriate level of reserves if it provides<br>additional financial security in the longterm.<br>It follows that this will form part of any formal<br>policy relating to holding reserves.|
|Details of fund materially in<br>deficit|Para 1.24|Not applicable.|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|Not applicable.|



## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

The charity’s principal sources of funds (including Para 1.47 any fundraising) 



|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|---|---|---|
|A description of the principal<br>risks facing the charity|Para 1.46||
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|CIO Foundation Constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees are the immediate close family<br>members of Luke Bell (& a close family<br>friend). Luke died from Neuroblastoma in<br>2018. The Charity was set up as his legacy.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|<br>Policies and procedures<br>adopted for the induction and<br>training of trustees|<br>Para 1.51||
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51||
|Other|||



## **Reference and Administrative details** 

|Charity name|Team Luke Foundation|
|---|---|
|Other name the charity uses|TeamLuke Foundation|
|Registered charity number|1185232|
|Charity’s principal address|3 Boundary View<br>Darlington<br>DL3 9BQ|
|||





**Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Mark Denton BELL|Chair|||
||Carol BELL|Trustee|||
||Graham Denton<br>BELL|Trustee|||
||Joseph Patrick<br>BUCHANAN|Trustee|||
||Rebecca BELL|Trustee|||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



– Corporate trustees names of the directors at the date the report was approved **Director name N/A** 

Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|**N/A**|||
||||
||||
||||
||||
||||





## **Funds held as custodian trustees on behalf of others** 

Description of the assets N/A held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

**Type of Name Address adviser N/A** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**<br>**Full name(s)**<br>**Position (eg Secretary,**<br>**Chair, etc)**<br>**Date**|Mark Bell|Carol Bell|
|---|---|---|
||||
||Mark Denton Bell|Carol Bell,<br>Trustee<br>11/01/2025|
||||
||Chair||
||14/01/2026||
||14/01/2026||






**Charity Name No (if any) Team Luke Foundation Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 4/1/2024 3/31/2025 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>Just GivingDonations/Gift Aid<br>**7,564**<br>Collection Boxes<br>**233**<br>Bank Interest<br>**758**<br>HMRC Gift Aid<br>**2,000**<br>FundraisingEvents<br>**4,020**<br>CompanyDonations<br>**3,410**<br>Personal Donations<br>**360**<br>Online Donations<br>**630**<br>**18,975**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                  18,975**<br>**A3 Payments**<br>Institute of Cancer Research Donation<br>**15,000**<br>Provision of Hospital Care Bags<br>**15,000**<br>Rugby& SwimmingFundraisingEvents<br>**1,380**<br>**1,880**<br>Secure Storage<br>**902**<br>Branded Sports Kit<br>**250**<br>ICR Travel Expenses<br>**-**<br>Vehicle Transport Costs & Maintenance<br>**970**<br>FundraisingPlatform Fees<br>**630**<br>**_Sub total_                      36,012**<br>**New Van Purchase 20/03/25**<br>**9,000**<br>**-**<br>**_Sub total_                        9,000**<br>**_Total payments_                  45,012**<br>**_Net of receipts/(payments)_ -                26,037**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**121,223**<br>**_Cash funds this year end_                  95,186**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>Design & Production of Promotional<br>Material<br>**A4 Asset and investment**<br>**purchases, (see table)**|**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**7,564**<br>**233**<br>**758**<br>**2,000**<br>**4,020**<br>**3,410**<br>**360**<br>**630**<br>**18,975**<br>**-**<br>**-**<br>**-**<br>**18,975**<br>**15,000**<br>**15,000**<br>**1,380**<br>**1,880**<br>**902**<br>**250**<br>**-**<br>**970**<br>**630**<br>**36,012**<br>**9,000**<br>**-**<br>**9,000**<br>**45,012**<br>**-                26,037**<br>**-**<br>**121,223**<br>**95,186**|**Last year**<br>**to the nearest £**|
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**7,564**|**18,019**|
||||**233**|**788**|
||||**758**|**1,463**|
||||**2,000**|**667**|
||||**4,020**|**2,266**|
||||**3,410**|**5,135**|
||||**360**|**366**|
||||**630**|**667**|
||||**18,975**|**29,371**|
||||||
|||**-**<br>**-**<br>**-**|**-**||
||||**-**|**-**|
||||**-**|**-**|
||||||
|||**-**|**18,975**|**29,371**|
||||||
|||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**15,000**|**15,000**|
||||**15,000**|**-**|
||||**1,380**|**1,386**|
||||**1,880**|**1,160**|
||||**902**|**-**|
||||**250**|**100**|
||||**-**|**318**|
||||**970**|**1,840**|
||||**630**|**620**|
||||**36,012**|**20,424**|
||||||
|||**-**<br>**-**<br>**-**|**9,000**||
||||**-**||
||||**9,000**|**-**|
||||||
|||**-**|**45,012**|**20,424**|
||||||
||**-**|**-**<br>**-**<br>**-**<br>**-**|**-                26,037**|**8,947**|
||**-**||**-**|**-**|
||**-**||**121,223**|**112,939**|
||**-**||**95,186**||





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>Van Transporter<br>**Details**<br>Signature<br>C. Bell<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Agreement Error<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>Main Charity Fund<br>**9,000**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Carol Bell<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**9,000**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||C. Bell|Carol Bell|14-Jan-26|
|||||



